11-beta-hydroxysteroid dehydrogenase 1
Also known as: HSD11, HSD11B1, HSD11L, SDR26C1
Function
Controls the reversible conversion of biologically active glucocorticoids such as cortisone to cortisol, and 11-dehydrocorticosterone to corticosterone in the presence of NADP(H). Participates in the corticosteroid receptor-mediated anti-inflammatory response, as well as metabolic and homeostatic processes. Plays a role in the secretion of aqueous humor in the eye, maintaining a normotensive, intraocular environment. Bidirectional in vitro, predominantly functions as a reductase in vivo, thereby increasing the concentration of active glucocorticoids. It has broad substrate specificity, besides glucocorticoids, it accepts other steroid and sterol substrates. Interconverts 7-oxo- and 7-hydroxy-neurosteroids such as 7-oxopregnenolone and 7beta-hydroxypregnenolone, 7-oxodehydroepiandrosterone (3beta-hydroxy-5-androstene-7,17-dione) and 7beta-hydroxydehydroepiandrosterone (3beta,7beta-dihydroxyandrost-5-en-17-one), among others. Catalyzes the stereo-specific conversion of the major dietary oxysterol, 7-ketocholesterol (7-oxocholesterol), into the more polar 7-beta-hydroxycholesterol metabolite. 7-oxocholesterol is one of the most important oxysterols, it participates in several events such as induction of apoptosis, accumulation in atherosclerotic lesions, lipid peroxidation, and induction of foam cell formation. Mediates the 7-oxo reduction of 7-oxolithocholate mainly to chenodeoxycholate, and to a lesser extent to ursodeoxycholate, both in its free form and when conjugated to glycine or taurine, providing a link between glucocorticoid activation and bile acid metabolism. Catalyzes the synthesis of 7-beta-25-dihydroxycholesterol from 7-oxo-25-hydroxycholesterol in vitro, which acts as a ligand for the G protein-coupled receptor (GPCR) Epstein-Barr virus-induced gene 2 (EBI2) and may thereby regulate immune cell migration.
Classification
- Family (Pfam)
- PF00106 adh_short
- InterPro
- 11-beta-HSD, NAD(P)-bd_dom_sf, Sc_DH/Rdtase_CS, SDR_fam
- Functional cluster
- Cytochrome P450 & Heme Enzymes
Experimental structures · PDB · 42
- 1XU7 X-ray 1.80A
- 1XU9 X-ray 1.55A
- 2BEL X-ray 2.11A
- 2ILT X-ray 2.30A
- 2IRW X-ray 3.10A
- 2RBE X-ray 1.90A
- 3BYZ X-ray 2.69A
- 3BZU X-ray 2.25A
- 3CH6 X-ray 2.35A
- 3CZR X-ray 2.35A
- 3D3E X-ray 2.60A
- 3D4N X-ray 2.50A
- … and 30 more
A predicted model is available from AlphaFold.
Gene Ontology · 10
- GO:0005789 endoplasmic reticulum membrane
- GO:0016020 membrane
- GO:0070524 11-beta-hydroxysteroid dehydrogenase (NADP+) activity
- GO:0047022 7-beta-hydroxysteroid dehydrogenase (NADP+) activity
- GO:0102196 cortisol dehydrogenase (NADP+) activity
- GO:0050661 NADP binding
- GO:0042803 protein homodimerization activity
- GO:0005496 steroid binding
- GO:0006713 glucocorticoid catabolic process
- GO:0006706 steroid catabolic process
Disease associations
- cortisone reductase deficiency 2 MONDO:0013842
Drugs targeting this protein · 6
- MK-0736 inhibitor
- AZD-4017 inhibitor
- BI-187004 inhibitor
- ABT-384 inhibitor
- BMS-823778 inhibitor
- CARBENOXOLONE inhibitor
Related proteins · sequence + function similarity
- 11-beta-hydroxysteroid dehydrogenase 1 0.99
- 11-beta-hydroxysteroid dehydrogenase 1 0.97
- 11-beta-hydroxysteroid dehydrogenase 1 0.97
- 11-beta-hydroxysteroid dehydrogenase 1 0.97
- 11-beta-hydroxysteroid dehydrogenase 1 0.96
- 11-beta-hydroxysteroid dehydrogenase 1 0.96
- 11-beta-hydroxysteroid dehydrogenase 1 0.96
- 11-beta-hydroxysteroid dehydrogenase 1 0.96
- Hydroxysteroid 11-beta-dehydrogenase 1-like protein A 0.91
- Hydroxysteroid 11-beta-dehydrogenase 1-like protein B 0.89
- Hydroxysteroid 11-beta-dehydrogenase 1-like protein 0.89
- Hydroxysteroid 11-beta-dehydrogenase 1-like protein 0.85
Co-cited proteins · studied together in the literature
- 11-beta-hydroxysteroid dehydrogenase 1 3 shared papers
- Arylacetamide deacetylase 1 shared papers
- GDH/6PGL endoplasmic bifunctional protein 1 shared papers
- 11-beta-hydroxysteroid dehydrogenase 1 1 shared papers
- 11-beta-hydroxysteroid dehydrogenase type 2 4 shared papers
- 11-beta-hydroxysteroid dehydrogenase 1 1 shared papers
- 11-beta-hydroxysteroid dehydrogenase 1 1 shared papers
- 3-oxo-5-alpha-steroid 4-dehydrogenase 2 1 shared papers
- 17-beta-hydroxysteroid dehydrogenase type 3 1 shared papers
- 17-beta-hydroxysteroid dehydrogenase type 3 1 shared papers
- 11-beta-hydroxysteroid dehydrogenase type 2 1 shared papers
- 11-beta-hydroxysteroid dehydrogenase type 2 1 shared papers
Literature · 29 cited papers
- Enzymatic interconversion of the oxysterols 7beta,25-dihydroxycholesterol and 7-keto,25-hydroxycholesterol by 11beta-hydroxysteroid dehydrogenase type 1 and 2. J. Steroid Biochem. Mol. Biol. · 2019
- Absence of 11-keto reduction of cortisone and 11-ketotestosterone in the model organism zebrafish. J. Endocrinol. · 2017
- An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J. Proteomics · 2014
- 11beta-hydroxyandrostenedione, the product of androstenedione metabolism in the adrenal, is metabolized in LNCaP cells by 5alpha-reductase yielding 11beta-hydroxy-5alpha-androstanedione. J. Steroid Biochem. Mol. Biol. · 2013
- Hepatic reduction of the secondary bile acid 7-oxolithocholic acid is mediated by 11beta-hydroxysteroid dehydrogenase 1. Biochem. J. · 2011
- Discovery and optimization of piperidyl benzamide derivatives as a novel class of 11beta-HSD1 inhibitors. Bioorg. Med. Chem. Lett. · 2009
- Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J. Proteome Res. · 2009
- Discovery of novel, potent benzamide inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) exhibiting oral activity in an enzyme inhibition ex vivo model. J. Med. Chem. · 2008
- Pyridine amides as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1. Bioorg. Med. Chem. Lett. · 2008
- Structural characterization and pharmacodynamic effects of an orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitor. Chem. Biol. Drug Des. · 2008
- The discovery of 2-anilinothiazolones as 11beta-HSD1 inhibitors. Bioorg. Med. Chem. Lett. · 2007
- Hexose-6-phosphate dehydrogenase modulates 11beta-hydroxysteroid dehydrogenase type 1-dependent metabolism of 7-keto- and 7beta-hydroxy-neurosteroids. PLoS ONE · 2007
- … and 17 more in the literature graph